Public Health

Morgan McSweeney, PhD, discusses America's public health decision-making, urging reforms to combat misinformation and safeguard scientific integrity in health agencies.

Jeffrey Bratberg, PharmD, BCPS, and Michelle Caetano, PharmD, BCACP, CVDOE, CDOE, BCPT, discuss the Pharmacy Bridge resource and pharmacists’ role in OUD management.

Conflicting federal health guidance creates confusion and erodes public trust, impacting patient safety and access to vital medical interventions.

Patient safety organizations began in the early 21st century to improve health care safety measures amongst various providers’ practices.

Catie Stimmel, PharmD, discusses the pharmacist’s role in ensuring PSOs operate at their intended capabilities.

Morgan McSweeney, PhD, discusses how social media highlights the most emotionally charged voices, often those offering anecdotes or outrage over careful analysis.

Catie Stimmel, PharmD, explores the confidentiality and non-punitive processes that are crucial in driving value toward patient safety organizations.

Catie Stimmel, PharmD, discusses what PSOs are and how they are protecting patients all across the US health care system.

High-profile figures often share misleading health information, highlighting the need for trusted and evidence-based content in social media discussions.

Experts at the Milken Institute address better ways of adopting pharmacy services within the greater health care ecosystem.

Conflicting health guidance from authorities creates confusion and erodes public trust, impacting access to medical care and long-term health outcomes.

A study reveals declining support for COVID-19 measures over time, highlighting the critical role of pharmacists in providing essential health education.

Study authors explore online purchasing habits for prescription-only and OTC medications.

Researchers explore highly engaged social media posts related to glucagon-like peptide-1 receptor agonists, attention deficit/hyperactivity disorder stimulants, and autoimmune biologics.

This collaboration is designed to bring resources addressing pharmacy shortages to the fingertips of the general public.

Living in West Virginia for over a decade, Mark Garofoli, PharmD, BCGP, CPE, CTTS, shares his experience as a practicing pharmacist amid the US opioid crisis.

Mark Garofoli, PharmD, BCGP, CPE, CTTS, shares his pain management expertise and discusses current developments in the US opioid epidemic.

Through diabetes education and initiatives focused on community health care, Clipper F. Young, PharmD, MPH, CDCES, BC-ADM, BCGP, is making a difference for patients and the pharmacy profession.

Pharmacists can help to address access issues, offer comprehensive medication counseling, and educate patients about disease management.

Using the PhotoVoice methodology, researchers conduct a study exploring Latinx adolescents’ preferences and the impacts of the COVID-19 pandemic and vaccine messaging.

Amid ongoing approaches to lower drug prices for US patients, like the Most-Favored-Nation policy, this is another partnership the Trump Administration believes will improve access challenges.

Amid recent measles outbreaks in Texas and Ohio, researchers aim to understand MMR vaccine coverage following postelimination outbreaks throughout the country.

While experts agree there is no one-size-fits-all approach, addressing medication nonadherence among patients presents opportunities for pharmacists to set themselves apart as medication counselors.

In part 3 of our interview with Andrew Maiorini, PharmD, FAHM, vice president of clinical programs at PerformRx, he discusses the ways in which his company is helping patients stay adherent on their medications.

Andrew Maiorini, PharmD, FAHM, vice president of clinical programs at PerformRx, discusses the ongoing issue of medication nonadherence and the pharmacists’ crucial role in managing it.